Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

2024 Vol. 42, No. 3

Cover Catalogue
Display Method:
Research progress on the regulation of intestinal flora and effect on intestinal absorption and transport by TCM components
JIANG Jun, CHEN Li, LI Zhong, LIU Jin’ge, QI Tian, ZHOU Tingting
2024, 42(3): 89-93, 120. doi: 10.12206/j.issn.2097-2024.202303012
Abstract(6250) HTML (4542) PDF (1260KB)(202)
Abstract:
The domestic and international research progress on the regulation of gut microbiota by Traditional Chinese Medicine (TCM) ingredients and their impact on intestinal absorption and transportation were summarized, which provided assistance for subsequ...
Research progress on natural medicines and active compounds in the treatment of heart failure
WU Xinyi, WAN Jingjing, LIU Xia
2024, 42(3): 94-100. doi: 10.12206/j.issn.2097-2024.202306013
Abstract(5074) HTML (4531) PDF (916KB)(48)
Abstract:
Heart failure is the terminal stage of various cardiovascular diseases and a leading cause of death. For a long time, natural medicines have been used to treat heart failure(HF) with remarkable effects. In this paper, the Traditional Chinese Medicine...
Preparation and in vitro dissolution behaviors evaluation of silymarin phospholipid complex
ZENG Qiping, LIU Jianqing, YANG Li'na, LIU Zhihong, SONG Hongtao
2024, 42(3): 101-107. doi: 10.12206/j.issn.2097-2024.202206051
Abstract(4112) HTML (2243) PDF (2971KB)(37)
Abstract:
Objective  To prepare silymarin phospholipids complex(SM-PC) and investigate its physicochemical properties.   Methods  On the basis of single-factor tests, the drug-lipid ratio, drug concentration and reaction temperature were selected as the fac...
Preparation and pharmacokinetics of flumazenil sublingual tablet
ZHANG Yingnan, HOU Cheng, XU Ziyi, LU Guangzhao, LU Ying, ZHANG He
2024, 42(3): 108-113. doi: 10.12206/j.issn.2097-2024.202305038
Abstract(6420) HTML (1463) PDF (1259KB)(37)
Abstract:
Objective  To prepare flumazenil sublingual tablets and study its bioavailability.   Methods  Flumazenil sublingual tablets were prepared by compressing flumazenil inclusion compound with hydroxypropyl-β-cyclodextrin as the inclusion material. In ...
Establishment of a high-throughput screening platform based on drug repurposing targeting alpha-1-acid glycoprotein and discovery of potential weight loss drugs
CHEN Feng, YANG Cirong, ZHANG Zhen, CHEN Fei, LIU Xia
2024, 42(3): 114-120. doi: 10.12206/j.issn.2097-2024.202309057
Abstract(3148) HTML (1598) PDF (1910KB)(15)
Abstract:
Objective  Alpha-1-acid glycoprotein (ORM) was a new target for the development of weight loss drugs. To search for potential weight loss drugs that could target ORM from the compound library of already marketed drugs based on drug repurposing.   M...
Improvement of gefitinib-resistance of PC9/GR by thapsigargin combined with gefitinib
DU Jiangyuan, ZHANG Lanlin, CAI Tongkai, CAO Yongbing
2024, 42(3): 121-126. doi: 10.12206/j.issn.2097-2024.202209018
Abstract(4279) HTML (1583) PDF (2154KB)(25)
Abstract:
Objective  To study the effect and mechanism of the thapsigargin combined with gefitinib on the proliferation of human lung adenocarcinoma gefitinib resistance cell line PC9/GR.   Methods  The cell viability of PC9/GR treated with gefitinib alone ...
Content measurement of doxorubicin hydrochloride and lonidamine by HPLC
SUN Yuhan, XU Ziyi, LIAO Jun, ZHANG He, FAN Li, LU Ying
2024, 42(3): 127-130. doi: 10.12206/j.issn.2097-2024.202306043
Abstract(3965) HTML (2361) PDF (986KB)(40)
Abstract:
Objective  To establish a method for the simultaneous determination of DOX·HCl and LND.   Methods  HPLC was performed on Agilent 5 HC-C18(2) (4.6 mm × 250 mm, 5 µm) column. The mobile phase was methanol-0.1% TFA aqueous solution, and the gradient ...
Observation of the prophylactic use of prokinetic agents in patients after tricuspid valve replacement under cardiopulmonary bypass
CHEN Qian, XU Xiangyang, LU Fanglin, HAN Lin, LI Bailing, XU Zhiyun
2024, 42(3): 131-134. doi: 10.12206/j.issn.2097-2024.202210060
Abstract(3224) HTML (1247) PDF (838KB)(18)
Abstract:
Objective  To analyze the postoperative therapeutic effect of prokinetic agents in patients after tricuspid valve replacement (TVR) under cardiopulmonary bypass.   Methods  Patients received TVR under cardiopulmonary bypass (during June 2010 to De...